Bavarian Nordic to Supply 200,000 Mpox Vaccine Doses to WHO Emergency Stockpile
Danish pharmaceutical company Bavarian Nordic has announced plans to supply and donate over 200,000 doses of its MVA-BN mpox vaccine. This contribution is intended to bolster the global mpox vaccine emergency stockpile, a strategic initiative recently launched by the World Health Organization (WHO). The move aims to strengthen international preparedness against mpox outbreaks by ensuring a ready supply of vaccines for high-risk areas. As a key provider in the mpox vaccine market, Bavarian Nordic's involvement supports the WHO's efforts to manage global health emergencies through coordinated resource distribution.
Topics: Mpox vaccine Vaccine supply WHO initiative